What is the efficacy of daratumumab in treating patients with refractory T-cell acute lymphoblastic leukemia (T-ALL) post stem cell transplant?
Year: 2026
Type: article
Abstract: No direct evidence for the efficacy of daratumumab in treating patients with refractory T-ALL post-stem cell transplant was identified, though some evidence from broader contexts suggests potential efficacy in related populations.
Author: Tripdatabase
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7225877207
